
location_onLogan Street, Downtown, Pittsburgh, Allegheny County, Pennsylvania, 15262, United States
OrganOx is a commercial-stage organ technology company dedicated to developing technologies that improve outcomes for patients with acute or chronic organ failure. Established as a spin-out of the University of Oxford in 2008, the company is now part of the Terumo Group. OrganOx is a pioneer in normothermic machine perfusion (NMP). Its flagship platform, the metra®, is available in the U.S., Europe, Canada, and Australia. It has been utilized in over 7,000 liver transplants to date to keep donor livers in a metabolically active state outside the body, enabling longer preservation times and functional assessment of the organ prior to transplant. This innovation leads to an increased number of organs available for transplant.
Founded in 1921, Terumo Corporation strives to fulfill its mission of "Contributing to Society through Healthcare" by providing a comprehensive range of solutions in the fields of therapeutic procedures, hospital operations, and life sciences in more than 160 countries and regions.
Work model: On-site
Logan Street, Downtown, Pittsburgh, Allegheny County, Pennsylvania, 15262, United States
Pittsburgh, Pennsylvania
Formal Lean 6 Sigma training
Skills: Sap, Sap Business One, Sap R/4 Hana, Powerbi, Sap Analytics, Microsoft Excel, Iso 13485, Fda, Bsi, Lean 6 Sigma.
Education: Undergraduate degree in a related subject or similar demonstratable experience.
OrganOx is a medical equipment manufacturer based in Oxford, England, specializing in advanced organ preservation technology. The company produces the OrganOx metra, a transportable, automated device designed for ex vivo liver perfusion. This technology was developed over a period exceeding 15 years by founders Professor Peter Friend and Professor Constantin Coussios, who initially worked at the University of Cambridge before continuing their research at the University of Oxford. OrganOx Limited was established in April 2008 as a spin-out from the University of Oxford.
The company offers an alternative to conventional cold preservation methods, which store livers at 4˚C in non-physiological solutions. Instead, OrganOx utilizes warm preservation to mimic the human body by continuously perfusing organs at physiological pressures and flows with oxygen-carrying red cells at 37˚C. This process provides nutrition, allowing the liver to remain functional during the preservation period by producing bile, metabolizing glucose, and maintaining a physiological pH.
This approach enables objective assessment of organ performance prior to transplant, extends preservation times, and creates potential for utilizing organs that might otherwise be discarded. The technology aims to transform transplantation outcomes through improved organ viability and assessment capabilities.
Browse more roles: All OrganOx jobs, engineering jobs on Recrutus.